These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29280228)

  • 1. An update on medication guides.
    Park LM; Jones PR; Pearsall BM; Araojo RT
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):129-132. PubMed ID: 29280228
    [No Abstract]   [Full Text] [Related]  

  • 2. Education becomes focus of classwide opioid REMS.
    Thompson CA
    Am J Health Syst Pharm; 2012 Aug; 69(16):1352. PubMed ID: 22855094
    [No Abstract]   [Full Text] [Related]  

  • 3. Congress investigates FDA's handling of antidepressant safety information.
    Young D
    Am J Health Syst Pharm; 2004 Nov; 61(21):2228, 2230, 2232 passim. PubMed ID: 15552624
    [No Abstract]   [Full Text] [Related]  

  • 4. Consumer medication leaflets inadequate, FDA says.
    Traynor K
    Am J Health Syst Pharm; 2009 Feb; 66(3):208, 210. PubMed ID: 19179632
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights October-December 2015.
    Office of Health & Constituent Affairs U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2016 Mar; 73(5):267. PubMed ID: 26896495
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and Drug Administration labeling and medication guides: A health outcomes critique.
    Watterson TL
    Res Social Adm Pharm; 2019 Sep; 15(9):1191-1192. PubMed ID: 31003764
    [No Abstract]   [Full Text] [Related]  

  • 8. Private-sector plan for patient information approved.
    Am J Health Syst Pharm; 1997 Feb; 54(4):352, 354. PubMed ID: 9043553
    [No Abstract]   [Full Text] [Related]  

  • 9. Wondering and musing.
    Archambault GF
    Drug Intell Clin Pharm; 1983 Dec; 17(12):917-9. PubMed ID: 6360613
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisapride and patient information leaflets.
    Sukkari SR; Sasich LD
    CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
    [No Abstract]   [Full Text] [Related]  

  • 11. Some patients may receive too much information about prescriptions.
    Lavine G
    Am J Health Syst Pharm; 2009 Apr; 66(8):696-7. PubMed ID: 19336824
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of consumer medication information in the United States, Europe, and Australia.
    Stockigt JR
    J Am Pharm Assoc (2003); 2008; 48(3):326; author reply 326, 331. PubMed ID: 18595818
    [No Abstract]   [Full Text] [Related]  

  • 13. Written patient information on prescription drugs. The evolution of government and voluntary programs in the United States.
    Nightingale SL
    Int J Technol Assess Health Care; 1995; 11(3):399-409. PubMed ID: 7591542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US FDA patient-reported outcome guidance: great expectations and unintended consequences.
    Fehnel S; DeMuro C; McLeod L; Coon C; Gnanasakthy A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):441-6. PubMed ID: 23977972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive study.
    Lambert BL; Schroeder SR; Galanter WL
    BMJ Qual Saf; 2016 Apr; 25(4):213-7. PubMed ID: 26700541
    [No Abstract]   [Full Text] [Related]  

  • 16. From the FDA: what's in a label? A guide for the anesthesia practitioner.
    Chang NS; Simone AF; Schultheis LW
    Anesthesiology; 2005 Jul; 103(1):179-85. PubMed ID: 15983471
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
    Harris JB; Holmes AP; Eiland LS
    Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rx package inserts: redesigned with fewer errors in mind.
    Fass JA; Seamon MJ; Cytacki J
    J Fam Pract; 2007 Jun; 56(6):438-41. PubMed ID: 17543253
    [No Abstract]   [Full Text] [Related]  

  • 20. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.